338.41MMarket Cap-2565P/E (TTM)
4.360High4.222Low100.97KVolume4.250Open4.220Pre Close434.86KTurnover0.24%Turnover RatioLossP/E (Static)78.52MShares8.09152wk High2.43P/B184.19MFloat Cap1.66052wk Low--Dividend TTM42.74MShs Float32.000Historical High--Div YieldTTM3.26%Amplitude1.640Historical Low4.306Avg Price1Lot Size
Tenaya Therapeutics Stock Forum
Just a bit of information
Furthermore, Tenaya’s second gene therapy product, TN-401, is targeting the treatment of arrhythmogenic right...
Very cool! Watching
Moomoo 24/7· 9 mins ago
TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
PKP2 Gene Replacement Therapy Normalized Heart Rhythms, Reversed Disease Progression and Extended Survival in a Severe Mouse Model of Disease
Tenaya Anticipates Dosing First ...
A bit more!
Update
This may be worth taking a look at this AM
TOP WATCH AH + 4/25 ⚡️⚡️
Daily Recap 4/24 ⚡️⚡️ some of latest alerts 👍🏼
NCPL (AH)
VIRI 👀
$Mullen Automotive(MULN.US)$$Bed Bath & Beyond Inc(BBBY.US)$$EyePoint Pharmaceuticals(EYPT.US)$$Appreciate Holdings(SFR.US)$$Tenaya Therapeutics(TNYA.US)$$Netcapital(NCPL.US)$$Virios Therapeutics(VIRI.US)$
No comment yet